Since NKT cells are CD3+, we purified CD3+CD56+ NKT cells and assessed their ability to kill PDL1+ C8161 human melanoma cells in the presence or absence of BiTE (Figure 6D). This evidence concerns the gene NCAM1 and melanoma.